Does BIVALIRUDIN Cause Vascular stent thrombosis? 63 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Vascular stent thrombosis have been filed in association with BIVALIRUDIN (BIVALIRUDIN). This represents 7.5% of all adverse event reports for BIVALIRUDIN.
63
Reports of Vascular stent thrombosis with BIVALIRUDIN
7.5%
of all BIVALIRUDIN reports
14
Deaths
15
Hospitalizations
How Dangerous Is Vascular stent thrombosis From BIVALIRUDIN?
Of the 63 reports, 14 (22.2%) resulted in death, 15 (23.8%) required hospitalization, and 13 (20.6%) were considered life-threatening.
Is Vascular stent thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIVALIRUDIN. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does BIVALIRUDIN Cause?
Drug ineffective (148)
Haemorrhage (79)
Off label use (73)
Thrombosis in device (63)
Heparin-induced thrombocytopenia (61)
Thrombosis (61)
Coagulation time abnormal (42)
Gastrointestinal haemorrhage (40)
Coronary artery thrombosis (33)
Cardiac arrest (28)
What Other Drugs Cause Vascular stent thrombosis?
TICAGRELOR (700)
CLOPIDOGREL BISULFATE (506)
ASPIRIN (379)
HEPARIN (178)
PRASUGREL (159)
RIVAROXABAN (95)
TIROFIBAN (63)
APIXABAN (32)
ENOXAPARIN (32)
CANGRELOR (29)
Which BIVALIRUDIN Alternatives Have Lower Vascular stent thrombosis Risk?
BIVALIRUDIN vs BLEOMYCIN
BIVALIRUDIN vs BLINATUMOMAB
BIVALIRUDIN vs BLONANSERIN
BIVALIRUDIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BIVALIRUDIN vs BOCEPREVIR